In small animal practice, we continue to see evolution in vaccine recommendations, particularly with updated guidelines emphasizing individualized risk-based protocols alongside core vaccines. There is also growing use of antibody titers in certain cases to help assess immunity, though they are not a replacement for vaccination in most scenarios. Vaccine hesitancy remains an ongoing challenge, and it's important to approach client concerns with education and transparency—explaining both the safety profile of modern vaccines and the risks of preventable diseases. Many veterinarians are addressing this by using clear communication, personalized vaccine schedules, and leveraging advancements in vaccine technology that aim to improve safety and efficacy. Overall, the shift is toward more tailored, evidence-based prevention strategies while maintaining strong public health standards.
Recent updates in core vaccine recommendations for pets emphasize both timing and individualized protocols based on age, lifestyle, and risk factors. Adjusting schedules to match a pet's specific exposure risks ensures optimal protection without over-vaccination. In practice, we're seeing some clients hesitant about annual vaccines, so clear communication and education about disease risks, benefits, and titer testing are essential for maintaining compliance. Explaining why each vaccine matters helps build trust and improve adherence. Advances in vaccine technology, such as recombinant vaccines and longer-duration immunities, allow for more tailored schedules and fewer injections while still ensuring protection. These innovations give veterinarians more flexibility in preventive care planning. Titers are increasingly used to guide decisions, especially for adult pets, to determine if immunity is sufficient and to reduce unnecessary vaccinations. Combining titers with client education and technology-driven vaccine options helps deliver evidence-based, individualized preventive care.